Core Viewpoint - The company has announced a profit distribution plan for the fiscal year 2024, which includes a cash dividend of 0.02 RMB per share, totaling approximately 22.68 million RMB to be distributed among shareholders [1][3]. Distribution Plan - The profit distribution plan was approved at the annual shareholders' meeting on May 14, 2025 [1]. - The total number of shares for the distribution is 1,134,078,509 [1]. - The cash dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the registration date [1]. Implementation Details - The cash dividends for unrestricted circulating shares will be distributed through the clearing system of the China Securities Depository and Clearing Corporation [1]. - Shareholders who have completed designated transactions can receive their cash dividends on the payment date at their designated securities business department [1]. Taxation Information - For individual shareholders holding unrestricted circulating shares for over one year, the cash dividend is exempt from personal income tax, resulting in a net distribution of 0.02 RMB per share [4]. - For individual shareholders holding shares for one year or less, the company will not withhold personal income tax at the time of distribution, but tax will be calculated upon the transfer of shares [4]. - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net cash dividend of 0.018 RMB per share [5][6]. Additional Information - The company will not issue bonus shares or increase capital through this distribution [2]. - The company has provided contact information for inquiries regarding the announcement [7][8].

Summary of Key Points Core Viewpoint - Hongchang Electronics (603002) has shown a positive stock performance with a closing price of 5.76 yuan as of June 6, 2025, reflecting a 2.67% increase from the previous week [1]. Company Announcements - The company announced a cash dividend of 0.02 yuan per share, with the A-share registration date set for June 12, 2025, and both the ex-dividend date and cash dividend payment date on June 13, 2025 [1]. - The profit distribution plan was approved at the annual shareholders' meeting on May 14, 2025, with a total cash dividend payout of 22,681,570.18 yuan based on a total share capital of 1,134,078,509 shares [1]. - Tax implications for shareholders include exemptions for individual shareholders and securities investment funds holding shares for over one year, while QFII investors will have a 10% withholding tax applied [1].

证券代码：603002 证券简称：宏昌电子 公告编号：2025-026 宏昌电子材料股份有限公司2024年年度 权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.02元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/12 | － | 2025/6/13 | 2025/6/13 | 差异化分红送转： 否 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 14 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本1,134,078,509股为基数，每股派发 现金红利0.02元（含税），共计派发 ...

Core Viewpoint - The company plans to increase the registered capital of its subsidiary, Zhuhai Hongchang Electronic Materials Co., Ltd., by a total of $3,800 million, enhancing its financial strength and supporting future business operations [2][3][12]. Investment Overview - The investment target is Zhuhai Hongchang Electronic Materials Co., Ltd., a subsidiary of Hongchang Electronic Materials Co., Ltd. [2] - The total investment amount includes an increase of $2,800 million from the company and an additional $1,000 million from its wholly-owned subsidiary, Hongkong Hongchang [3][4]. - After the capital increase, Zhuhai Hongchang's registered capital will rise from $8,590 million to $12,390 million [4]. Financial Performance of Zhuhai Hongchang - As of December 31, 2024, Zhuhai Hongchang reported total assets of approximately ¥2,130 million, total liabilities of about ¥1,400 million, and a net asset value of around ¥729 million [8]. - For the fiscal year 2024, Zhuhai Hongchang achieved revenue of approximately ¥1,249 million and a net profit of about ¥24 million [8]. - In 2023, the company had total assets of approximately ¥1,796 million, total liabilities of about ¥1,063 million, and a net asset value of around ¥733 million, with revenue of approximately ¥1,379 million and a net profit of about ¥54 million [9]. Board Approval and Decision-Making - The board of directors approved the capital increase in two meetings, with unanimous support [9][12]. - The investment decision falls within the board's authority and does not require shareholder approval [7][12]. Impact on the Company - The capital increase will not affect the company's control over Zhuhai Hongchang and is expected to optimize the asset-liability structure, enhancing financial strength [12]. - The investment is aimed at supporting Zhuhai Hongchang's operational activities and new project investments [12].

Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]

宏昌电子材料股份有限公司关于 全资子公司香港宏昌向子公司珠海宏昌电子材料 有限公司增资公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 投资标的名称: 珠海宏昌电子材料有限公司（以下简称"珠海宏昌"）， 为宏昌电子材料股份有限公司（以下简称"宏昌电子"或"公司"）子公司。 投资金额：宏昌电子材料有限公司（EPOXY BASE(H.K.) ELCTRONIC MATERIAL LIMITED）（以下简称"香港宏昌"）为公司全资子公司，拟向珠海宏 昌增加注册资本 1,000 万美元，本次增资后，珠海宏昌注册资本为 12,390 万美 元。 本次对外投资尚需有关部门的审批或备案，是否顺利实施存在一定的不 确定性，敬请投资者注意投资风险。 根据《公司章程》等相关规定，本次对外投资属董事会决策权限范围之 内，无须提交公司股东大会审议批准。 证券代码：603002 证券简称：宏昌电子 公告编号：2025-025 一、对外投资概述 为谋求长远发展，公司于 2025 年 5 月 7 日召开第六届董事会第十六次会议 审 ...

Group 1 - The core point of the article is that Hong Kong Macrotron plans to increase the registered capital of its subsidiary Zhuhai Macrotron by 10 million USD, raising the total registered capital to 124 million USD [1] - The funding for this capital increase will come from Hong Kong Macrotron's own funds, aimed at enhancing the financial strength of Zhuhai Macrotron and optimizing its asset-liability structure [1] - The capital increase is subject to approval or filing with relevant authorities, indicating a level of uncertainty regarding the process [1]

中国北京建国门外大街 1 号国贸写字楼 2 座 12 -15 层 100004 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com 北京市通商律师事务所 关于宏昌电子材料股份有限公司 致：宏昌电子材料股份有限公司 受宏昌电子材料股份有限公司（以下简称"公司"）聘请，北京市通商律师事 务所指派律师（以下简称"本所律师"）出席了公司 2024 年年度股东大会，并依 据《中华人民共和国公司法》（以下简称"《公司法》"）《上市公司股东会规则》 等法律、法规、规章、规范性文件及《宏昌电子材料股份有限公司章程》（以下 简称" 《公司章程》"）的规定，本所律师对公司本次股东大会召集及召开程序、 出席会议的人员资格、召集人资格、提案审议情况、股东大会的表决方式、表决 程序和表决结果等重要事项的合法性进行了审核和见证，现出具本法律意见书如 下： 一、 本次股东大会的召集与召开程序 本次股东大会由公司第六届董事会第十四次会议决议召集。公司于 2025 年 《证券时报》 ...

证券代码：603002 证券简称：宏昌电子 公告编号：2025-024 宏昌电子材料股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 本次会议是否有否决议案：无 一、 会议召开和出席情况 份总数的比例（%） 54.4017 (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会采取现场投票与网络投票相结合的方式召开。本次股东大会由 公司董事会召集，董事长林瑞荣先生主持，会议的召集和召开程序、出席会议人 员的资格、会议的表决方式和程序均符合相关法律、法规及《公司章程》等的有 关规定。 (五) 公司董事、监事和董事会秘书的出席情况 二、 议案审议情况 (一)非累积投票议案 审议结果：通过 (一) 股东大会召开的时间：2025 年 5 月 14 日 (二) 股东大会召开的地点：广州市黄埔区开创大道 728 号保利中创孵化器 3 号 楼 212 室公司会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 表决情况： | 股东类型 | 同意 | | ...

中国北京建国门外大街 1 号国贸写字楼 2 座 12-15 层 100004 12-15th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com 北京市通商律师事务所 关于宏昌电子材料股份有限公司 2024 年年度股东大会的法律意见书 致：宏昌电子材料股份有限公司 受宏昌电子材料股份有限公司（以下简称"公司"）聘请，北京市通商律师事 务所指派律师（以下简称"本所律师"）出席了公司 2024 年年度股东大会，并依 据《中华人民共和国公司法》（以下简称"《公司法》"）《上市公司股东会规则》 等法律、法规、规章、规范性文件及《宏昌电子材料股份有限公司章程》（以下 简称"《公司章程》"）的规定，本所律师对公司本次股东大会召集及召开程序、 出席会议的人员资格、召集人资格、提案审议情况、股东大会的表决方式 ...